FR EA

Contract analysis

Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.

Contract analysis / exhibit-g-ip-publication-rights.docx
exhibit-g-ip-publication-rights.docx
1018-00004 · 1 clauses
High · 1 Medium · 0 Standard · 0
EXHIBIT G High
⚑ Non-compete / exclusivity restraint
EXHIBIT G INTELLECTUAL PROPERTY AND PUBLICATION RIGHTS Attached to and incorporated by reference into the Master Clinical Trial Agreement dated June 28, 2023 (the "Agreement") by and between Penterra Pharmaceuticals Corp., a Delaware corporation ("Sponsor"), and Veridian Health Research Network, Inc., a Delaware 501(c)(3) corporation ("Site Network"). Protocol: PPC-4871-III (CLARION — Clinical Assessment of Response